BIORA THERAPEUTICS INC (PROG)
US74319F1075 - Common Stock
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -247.41M | -192.53M | -148.04M | -129.11M | |||
| Depreciation Amortization | 1.44M | 5.06M | 6.35M | 6.07M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | 6.25M | |||
| Change In Working Capital | -25.86M | -51.17M | 32.65M | 46.16M | |||
| Interest Paid | 7.54M | 3.93M | 7.53M | 7.62M | |||
| Taxes Paid | 367.00K | 60.00K | 10.00K | 210.00K | |||
| Other non cash items | 104.35M | 72.90M | 2.91M | 5.50M | |||
| OPERATING CASH FLOW | -167.49M | -165.74M | -106.12M | -65.13M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -855.00K | -4.94M | -3.73M | -4.83M | |||
| Other Investing Activity | -387.00K | 0.00 | 20.25M | 60.66M | |||
| INVESTING CASH FLOW | -1.24M | -4.94M | 16.53M | 55.83M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | -1.64M | 98.73M | -1.28M | -1.75M | |||
| Stock Issued/Repurchased | 172.22M | 137.74M | 79.59M | -10.81M | |||
| Other Financing Activity | -5.53M | -6.75M | -4.68M | -250.00K | |||
| FINANCING CASH FLOW | 165.05M | 229.72M | 73.64M | -12.81M | |||
| CHANGE IN CASH | -3.68M | 59.04M | -15.95M | -22.11M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -167.49M | -165.74M | -106.12M | -65.13M | |||
| Capital Expenditure | -855.00K | -4.94M | -3.73M | -4.83M | |||
| FREE CASH FLOW | -168.34M | -170.68M | -109.85M | -69.96M | |||
All data in USD